Immunomodulating drugs

Umifenovir (trade name Russian: Арбидол, Chinese: 阿比朵尔) is an antiviral treatment for influenza infection used in Russia and China.

Immunotherapy is the "treatment of disease by inducing, enhancing, or suppressing an immune response".

Glatiramer acetate (also known as Copolymer 1, Cop-1, or Copaxone - as marketed by Teva Pharmaceuticals) is an immunomodulator drug currently used to treat multiple sclerosis.

Tilorone (trade names Amixin, Lavomax and others) is the first recognized synthetic, small molecular weight compound that is an orally active interferon inducer.

Azoximer bromide is a macromolecular compound with high-molecular weight and high immunomodulating activity.

BMS-470539 is a small-molecule drug which acts as a potent and highly selective full agonist of the MC1 receptor.

Talimogene laherparepvec (tal im' oh jeen la her" pa rep' vek), (T-Vec, tradenamed Imygic, formerly called OncoVEXGM-CSF) is a biopharmaceutical drug to treat melanoma lesions that cannot be operated on; it is injected directly into the lesion.

Immunocore is a privately owned British clinical-stage biotechnology company, based in Oxfordshire, which researches and develops cancer treatments using T-cell receptors (TCRs).

Kite Pharma is a publicly held, clinical-stage biopharmaceutical company engaged in the development of novel cancer immunotherapy products with a primary focus on engineered autologous T cell therapy (eACT™) designed to restore the immune system's ability to recognize and eradicate tumors.

Semapimod (INN), formerly known as CNI-1493, is an investigational new drug which has anti-inflammatory, anti-cytokine, immunomodulatory, antiviral and antimalarial properties.

Lobenzarit (INN) is a drug used in the treatment of arthritis.

Interferon alfa (INN) or HuIFN-alpha-Le, trade name Multiferon, is a pharmaceutical drug composed of natural interferon alpha (IFN-α) obtained from the leukocyte fraction of human blood following induction with Sendai virus.